Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 8/2012

01-08-2012 | Letter to the Editor

Prothrombin complex concentrate (Octaplex®) for postsurgical bleeding control in a Stauffer’s syndrome

Authors: Ana B. Fernández, Azahara Sancho de Ávila

Published in: Annals of Hematology | Issue 8/2012

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Stauffer MH (1961) Nephrogenic hepatosplenomegaly. Gastroenterology 40:694
2.
Kranidiotis GP, Voidonikola PT, Dimopoulos MK, Anastasiou-Nana MI (2009) Stauffer’s syndrome as a prominent manifestation of renal cancer: a case report. Cases J 2(1):49PubMedCrossRef
3.
Schick KS, Fertmann JM, Jauch K-W, Hoffmann JN (2009) Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 13(6):R191PubMedCrossRef
4.
Stuklis RG, O'Shaughnessy DF, Ohri SK (2001) Novel approach to bleeding in patients undergoing cardiac surgery with liver dysfunction. Eur J Cardiothorac Surg 19(2):219–220PubMedCrossRef
5.
Böhrer H (1999) Prothrombin complex concentrate substitution during liver transplantation. Thromb Res 95(4 Suppl 1):S71–S74PubMedCrossRef
Metadata
Title
Prothrombin complex concentrate (Octaplex®) for postsurgical bleeding control in a Stauffer’s syndrome
Authors
Ana B. Fernández
Azahara Sancho de Ávila
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 8/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1396-8

Other articles of this Issue 8/2012

Annals of Hematology 8/2012 Go to the issue

Original Article

P. aeruginosa bloodstream infections among hematological patients: an old or new question?

Original Article

The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients

Original Article

Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor

Original Article

Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia

Original Article

Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells

Original Article

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits